Date Filed | Type | Description |
08/25/2023 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
08/25/2023 |
N-PX
| Form N-PX - Annual Report of proxy voting record of management investment companies: |
07/06/2023 |
3
| Wasserman Aaron David (Chief Compliance Officer) has filed a Form 3 on BlackRock Health Sciences Trust |
05/26/2023 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
05/23/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/24/2023 |
40-17G
| Form 40-17G - Fidelity Bond [Rule 17G-1(g)]: |
03/10/2023 |
N-CEN
| Form N-CEN - Annual Report for Registered Investment Companies: |
03/07/2023 |
N-CSR
| Form N-CSR - Certified Shareholder Report: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Accettella Christopher (Portfolio Manager) has filed a Form 4 on BlackRock Health Sciences Trust
Txns:
| Disposed/sold 206 shares
@ $43.56, valued at
$9k
Granted 155 options to buy
@ $43.56, valued at
$6.8k
Exercised 74 options to buy
@ $0 Exercised 65 options to buy
@ $0 Exercised 68 options to buy
@ $0 |
|
02/02/2023 |
4
| Lee Jeffrey Gene (Portfolio Manager) has filed a Form 4 on BlackRock Health Sciences Trust
Txns:
| Disposed/sold 205 shares
@ $43.56, valued at
$8.9k
Granted 83 options to buy
@ $43.56, valued at
$3.6k
Exercised 129 options to buy
@ $0 Exercised 76 options to buy
@ $0 |
|
01/03/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
11/25/2022 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
09/01/2022 |
N-CSRS
| Form N-CSRS - Certified Shareholder Report, Semi-Annual: |
08/25/2022 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
08/25/2022 |
N-PX
| Form N-PX - Annual Report of proxy voting record of management investment companies: |
07/15/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
06/03/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
05/26/2022 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
04/26/2022 |
POS EX
| Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]: |
04/26/2022 |
424B2
| Form 424B2 - Prospectus [Rule 424(b)(2)]: |
04/26/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
04/21/2022 |
N-2/A
| Form N-2/A - Registration statement for closed-end investment companies: [Amend] |
03/15/2022 |
N-CEN
| Form N-CEN - Annual Report for Registered Investment Companies: |
03/14/2022 |
N-2
| Form N-2 - Registration statement for closed-end investment companies: |
03/04/2022 |
N-CSR
| Form N-CSR - Certified Shareholder Report: |
02/25/2022 |
NPORT-P
| Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public): |
02/03/2022 |
4
| McClements Kyle (Portfolio Manager) has filed a Form 4 on BlackRock Health Sciences Trust
Txns:
| Disposed/sold 632 shares
@ $45.1, valued at
$28.5k
Granted 707 options to buy
@ $45.1, valued at
$31.9k
Exercised 201 options to buy
@ $0 Exercised 144 options to buy
@ $0 Exercised 287 options to buy
@ $0 |
|
02/03/2022 |
4
| Accettella Christopher (Portfolio Manager) has filed a Form 4 on BlackRock Health Sciences Trust
Txns:
| Disposed/sold 203 shares
@ $45.1, valued at
$9.2k
Granted 208 options to buy
@ $45.1, valued at
$9.4k
Exercised 61 options to buy
@ $0 Exercised 64 options to buy
@ $0 Exercised 78 options to buy
@ $0 |
|
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2022 |
4
| Xie H Erin (Portfolio Manager) has filed a Form 4 on BlackRock Health Sciences Trust
Txns:
| Disposed/sold 15,617 shares
@ $45.1, valued at
$704.3k
Granted 15,174 options to buy
@ $45.1, valued at
$684.3k
Exercised 4,359 options to buy
@ $0 Exercised 3,739 options to buy
@ $0 Exercised 7,518 options to buy
@ $0 |
|
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|